Envision Report

Published January 30, 2018

Asia-Pacific Point-of-care Diagnostic Market – Size, Outlook, Trends and Forecasts (2018 – 2024)

Download Free Sample Report!

Point-of-care testing is medical diagnostic testing or near point-of-care testing. Point-of-care tests are simple medical tests that are performed and develop new technology to mask the complexity. Connectivity is an important part of the point-of-care market.

Asia-Pacific Point-of-care Diagnostic Market Segments size & growth:

The market is valued at $ 2.603 billion in 2017 and is projected to $ 4.344 billion by 2024 at a CAGR of 9.9%. The significant factors that are driving the growth of the market are an increase in awareness and inclination towards home health care, and prevalence of lifestyle and infectious disease and demand for the market is expected to grow in the further years. Rapid growth in ageing population, advancements in technology and increase in some chronic diseases.

Asia-Pacific Point-of-care Diagnostic Market Share:

Point-of-care diagnostics market is categorised by by-product, mode of delivery and end user. By by-product, it is segmented into infectious disease, glucose monitoring kit, oncology markers, coagulation, drugs of abuse and blood gas testing and others. Based on the mode of delivery the market is categorised into OTC testing and prescription. And based on end users the market is segmented into research laboratories, home health care, and hospitals. As by-product categorises the market, mode of delivery and end user the market equally constitutes the market share in all the categories like hospitals, research laboratories and home health care, testing and monitoring. Geographically, Asia-Pacific is a fastest growing segment and exhibit strong growth rate during the forecast (2018-24)

Asia-Pacific Point-of-care Diagnostic Market Trends:

  • Roche, Alere, Abbott, and Siemens are the ones which are the most significant companies regarding point-of-care diagnostics market revenues and these companies together make three-fourths of entire POC diagnostics market.
  • Waltham, MA-based Alere secured the second market position and participated in nearly all the POC segments but dominates in cardiac markers.

 Asia-Pacific Point-of-care Diagnostic Market Research Reports Include:

An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.

To have complete market analysis, industry value chain analysis, Porter’s Five Force Analysis, PESTLE, SWOT analysis, and Y-o-Y analysis were carried to understand the market more comprehensively.

Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year

Identifying DROC in the current market and their impact in altering the market dynamics.

Competitive landscape analysis to identify the mergers and acquisitions which will have a comparative financial study with significant competitors.

Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.

The primary market players are:

  • Abbott Laboratories
  • Siemens AG
  • Johnson & Johnson
  • Alere Inc.
  • Nova Biomedical
  • Roche Diagnostics


1 Introduction

   1.1 Executive Summary

   1.2 Market Definition

   1.3 Scope of the Study

2 Research Methodology

   2.1 Secondary Research

   2.2 Primary Research

   2.3 Analytic Tools and Model

   2.4 Economic Indicator

         2.4.1 Base Year, Base Currency, Forecasting Period

   2.5 Expert Validation

   2.6 Study Timeline

3 Market Analysis

   3.1 Industry Value Chain Analysis

   3.2 Porter’s Five Analysis

         3.2.1 Bargaining Power of Buyers

         3.2.2 Bargaining Power of Suppliers

         3.2.3 Threats of Substitutes

         3.2.4 Threats of New Entrants

         3.2.5 Industry Rivalry

   3.3 Pestle Analysis

         3.3.1 Political

         3.3.2 Economical

         3.3.3 Social

         3.3.4 Technological

         3.3.5 Legal

         3.3.6 Environmental

   3.4 SWOT Analysis

          3.4.1 Strengths

          3.4.2 Weakness

          3.4.3 Opportunities

          3.4.4 Threats

          3.5 Y-O-Y Analyses

4 Market Dynamics

    4.1 Drivers

           4.1.1 Increasing prevalence of chronic and infectious diseases.

           4.1.2 Initiatives implemented by government and not-for-profit associations for rising health awareness.

           4.1.3 Technological advancements and adoption of a home-based point of care devices and new product launches.

           4.1.4 Increase in worldwide expenditures on healthcare.

           4.1.5 Increase in usage of home-based POC devices due to the shortage of skilled laboratory technicians.

    4.2 Restraints

           4.2.1 Lack of coordination among organisations (healthcare).

           4.2.2 High procedure costs.

           4.2.3 Inadequate reimbursement policies for point of care diagnostics devices.

           4.2.4 Product prices and hampering profits.

           4.2.5 Time-consuming policies, therefore, increasing gestation period for product launches.

    4.3 Opportunities

           4.3.1 Miniaturization of testing devices.

           4.3.2 Developing economies after lucrative growth opportunities and increasing number of conferences and events.

    4.4 Challenges

           4.4.1 Irresponsible towards the change of treatment practices.

           4.4.2 Lack of professionals and lack of knowledge on POC devices.

5 Asia-Pacific Point of Care Diagnostics Market – By Product

   5.1 Introduction

   5.2 Infectious diseases

   5.3 Cardio metabolic kits

   5.4 Glucose monitoring kits

   5.5 Oncology markers

   5.6 Coagulation

   5.7 Urinalysis

   5.8 OTC diagnostics test

   5.9 Drugs of abuse

   5.10 Blood gas testing

   5.11 Fertility testing

  5.12 Others

 6 Asia-Pacific Point of Care Diagnostics Market – By mode of delivery

  6.1 Introduction

  6.2 OTC testing

  6.3 Prescription

 7 Point of Care Diagnostics Market – By End-user

  7.1 Introduction

  7.2 Hospitals

  7.3 Research laboratories

  7.4 Home healthcare

   7.5 Others

8 Asia-Pacific Point of Care Diagnostics Market – By Geography

    8.1 Asia-pacific

         8.1.1 Introduction

         8.1.2 China

         8.1.3 Japan

         8.1.4 India

         8.1.5 Australia

         8.1.6 Others

9 Asia-Pacific Point of Care Diagnostics – Competitive Landscape

   9.1 Mergers & Acquisitions, Joint Ventures, Collaborations, and Agreements

   9.2 Market Share Analysis

   9.3 Strategies Adopted By Top Companies

 10 Asia-Pacific Point of Care Diagnostics – Company Profiles

    10.1 Abbott laboratories

     10.2 Siemens AG

     10.3 Dickinson and company

     10.4 PTS diagnostics

     10.5 Nova biomedical

     10.6 Werfenlife

     10.7 Alere Inc.

     10.8 Becton

     10.9 Beckman Coulter, Inc.

     10.10 Johnson & Johnson Services Inc

     10.11 Instrumentation laboratory

11 Market Insights

    11.1 Insights of Industry Experts

    11.2 Analyst Opinion (Market Understanding)

    11.3 Investment Opportunities

12 Appendix

    12.1 List of Tables

    12.2 List of Figures

  • Competitive Analysis in marketing and strategic management is an assessment of the strengths and weaknesses of current and potential competitors.
  • Monitoring the external and internal factors which affect the market dynamics with the aid of PESTLE analysis.
  • The Regional and Global Variety is taken care of in the report.
  • Year on Year basis generation of revenue is studied.
  • Porter's Five Forces analyze the intensity of competition in an industry and its profitability level.
  • The overview and the sustainability of the market are analyzed through SWOT.
  • DROC is recognized in the current market scenario and see how its effect on market dynamics.
  • The segment-level analysis in terms of type and technology.
  • The value chain analysis, value that's created and captured by a company is the profit margin.Value
  • Created and Captured – Cost of Creating that Value = Margin
  • An executive summary consists of the whole report and the outcome is been given in the report to have brief knowledge about the report.
  • Basis on the depth of the study we approach using analytical tools
  • Expertise investment opportunities are given after analyzing the market to give the organization and the individual to have perfect knowledge about the market.


©2018 - Envision Inteligence | All Rights Reserved.